Biolinq is a startup that has developed a proprietary wearable biosensor platform that is capable of measuring blood level information, without the need to draw blood. We are developing products that are changing the way patients and consumers access information about their body, by making new levels of actionable information readily available. We are dedicated to the personal and professional growth of all our team members and strive to create a positive and creative work environment.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $14.75M
Investors 6
| Date | Name | Website |
| - | M Ventures | m-ventures... |
| - | T1D Fund | t1dfund.or... |
| - | Startup Le... | startuplea... |
| - | Biobrit | biobrit.co... |
| - | Alpha Wave... | alphawaveg... |
| - | LifeSci Ve... | lifesciven... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.03.2019 | Series A | $4.75M | - |
| 27.11.2017 | Series A | $10M | - |
Mentions in press and media 14
| Date | Title | Description |
| 23.03.2021 | Biolinq has raised $5.22M in new funding | - |
| 01.04.2019 | Biolinq raises an extra $4.75M in series A for trials of its painless diabetes sensor | Biolinq has tacked on an extra $4.75 million to the total of its series A round to help fund additional clinical trials and development of its coin-sized sensor patch for monitoring blood glucose levels and other biomarkers. The additional ... |
| 01.04.2019 | Biolinq raises an extra $4.75M in series A for trials of its painless diabetes sensor | Biolinq has tacked on an extra $4.75 million to the total of its series A round to help fund additional clinical trials and development of its coin-sized sensor patch for monitoring blood glucose levels and other biomarkers. Sponsored by Ag... |
| 28.03.2019 | Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring | Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Ca... |
| 28.03.2019 | Biolinq Expands Series A Financing With $4.75M Investment | Biolinq, a San Diego, CA-based health technology company, expanded its Series A financing with an additional investment of $4.75m. The round was led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners, which joined a syndica... |
| 28.03.2019 | Term Sheet — Thursday, March 28 | CASPER THE FRIENDLY UNICORN Another day, another unicorn. Casper just raised $100 million in funding at a post-money valuation of $1.1 billion. The startup will use the capital to expand internationally and grow its physical retail stores. ... |
| 28.03.2019 | Biolinq Gets $4.75M For Biosensors, Eyes Glucose Monitoring Market | San Diego-based biotech startup Biolinq, which is developing wireless-enabled biosensor patches for continuous monitoring of biomarkers, has raised $4.75M additional Series A funding, the company said this morning. The funding came from JDR... |
| 28.03.2019 | Daily funding roundup - March 28th, 2019 | BillionToOne raised $15M; Polyneuron Pharmaceuticals secured $22.6M;Prevail Therapeutics lands $50M Artiphon: Artiphon is empowering a new generation to explore music-making with smart instruments and adaptive software. Artiphon has raised ... |
| 28.03.2019 | Digital health company developing minimally invasive CGM Biolinq raises additional $4.75M | Photo credit: Biolinq |
| 28.11.2017 | Term Sheet — Tuesday, November 28 | THREE THINGS Good morning, Term Sheet readers! Paid Content You can't secure what you can't see From ExtraHop From a seller’s standpoint, the value proposition [for the SoftBank tender offer] is that they are able to liquidate their holding... |
Show more